<DOC>
	<DOCNO>NCT02275468</DOCNO>
	<brief_summary>prospective , multicenter ( outpatient clinic three participate hospital Beijing ) , double blind randomize placebo-controlled study . The study consist 2-week run-in period 12-month treatment period .</brief_summary>
	<brief_title>Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function Patients CKD Stage 3 4</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>( 1 ) Signed informed consent age 18 75 year old . ( 2 ) Chronic renal disease Glomerular Filtration Rate ( GFR ) estimate use CKD Epidemiology Collaboration ( CKDEPI ) equation 15 59 ml/min per 1.73 m2 least 2 date separate least 90 day 6 month ( CKD define window period ) . ( 3 ) Not receive TCM treatment least 2 week . ( 1 ) 50 % increase serum creatinine occur within 2 month screening . ( 2 ) Immediate need dialysis . ( 3 ) Myocardial infarction cerebrovascular accident 6 month precede trial . ( 4 ) Connectivetissue disease , obstructive uropathy renal transplantation . ( 5 ) Patients severe disease organ cancer , psychotic disease , active tuberculosis . ( 6 ) Treatment corticosteroid immunosuppressive agent recent 3 month . Hemoglobin ( Hb ) less 80 g/L . ( 7 ) Diabetes Mellitus uncontrolled Blood Sugar ( glycated hemoglobin （HbA1c） ＞8.0 % ) . ( 8 ) Enrolled trial . ( 9 ) Women pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>eGFR slope</keyword>
	<keyword>Herbal medicine Fu-zheng-qu-zhuo Oral liquid</keyword>
</DOC>